Autologous skin substitute for hard-to-heal ulcers: Retrospective analysis on safety, applicability, and efficacy in an outpatient and hospitalized setting

Wound Repair and Regeneration

Volumn 21, Issue 5, 2013, Pages 667-676

  Blok, Chantal S ^a   Vink, Liselot ^a   De Boer, Edith M ^a   Van Montfrans, Catherine ^a   Van Den Hoogenband, Henk M ^a   Mooij, Michael C ^c   Gauw, Stefanie A ^c   Vloemans, Jos A F P M ^d   Bruynzeel, Ineke ^e   Van Kraan, Aleid ^f   Kuik, Joop ^a   Waaijman, Taco ^a   Scheper, Rik J ^a   Gibbs, Susan ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Centrum Oosterwal Dermatologie and Flebologie   (Netherlands)

^d RED CROSS HOSPITAL   (Netherlands)

^e GROENE HART HOSPITAL   (Netherlands)

^f Waterland Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR DERMAL MATRIX; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; DECUBITUS; FEMALE; FOLLOW UP; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SAFETY; SKIN TRANSPLANTATION; ULCER HEALING; VACUUM ASSISTED CLOSURE;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OUTPATIENTS; RETROSPECTIVE STUDIES; SKIN, ARTIFICIAL; TIME FACTORS; TREATMENT OUTCOME; ULCER; WOUND HEALING;

EID: 84883489088     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12082     Document Type: Article

References (34)

1. Campbell C, Parish LC,. The decubitus ulcer: facts and controversies. Clin Dermatol 2010; 28: 527-532.
2. Korber A, Klode J, Al-Benna S, Wax C, Schadendorf D, Steinstraesser L, et al. Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey. J Dtsch Dermatol Ges 2010; 25: 306-310.
3. Mekkes JR, Loots MA, van der Wal AC, Bos JD,. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003; 148: 388-401.
4. Valencia IC, Falabella A, Kirsner RS, Eaglstein WH,. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001; 44: 401-421.
5. Margolis DJ, Bilker W, Santanna J, Baumgarten M,. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002; 46: 381-386.
6. Korting HC, Callies R, Reusch M, Schlaeger M, Sterry W,. [Dermatological guideline efforts for 2007 in perspective]. J Dtsch Dermatol Ges 2007; 5: 1-3.
7. Ruckley CV,. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997; 48: 67-69.
8. Purwins S, Herberger K, Debus ES, Rustenbach SJ, Pelzer P, Rabe E, et al. Cost-of-illness of chronic leg ulcers in Germany. Int Wound J 2010; 7: 97-102.
9. Gonzalez-Consuegra RV, Verdu J,. Quality of life in people with venous leg ulcers: an integrative review. J Adv Nurs 2011; 67: 926-944.
10. O'Meara S, Cullum NA, Nelson EA,. Compression for venous leg ulcers. Cochrane Database Syst Rev 2009; (1): CD000265.
11. Edmonds M,. Diabetic foot ulcers: practical treatment recommendations. Drugs 2006; 66: 913-929.
12. Jones JE, Nelson EA,. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev 2007; (2): CD001737.
13. O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG,. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2010; (1): CD003557.
14. Palfreyman S, Nelson EA, Michaels JA,. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007; 335: 244.
15. Vikatmaa P, Juutilainen V, Kuukasjarvi P, Malmivaara A,. Negative pressure wound therapy: a systematic review on effectiveness and safety. Eur J Vasc Endovasc Surg 2008; 36: 438-448.
16. Wu SC, Marston W, Armstrong DG,. Wound care: the role of advanced wound-healing technologies. J Am Podiatr Med Assoc 2010; 100: 385-394.
17. Limova M,. Active wound coverings: bioengineered skin and dermal substitutes. Surg Clin North Am 2010; 90: 1237-1255.
18. Kirsner RS, Marston WA, Snyder RJ, Lee TD, Cargill DI, Slade HB,. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2012; 380: 977-985.
19. Jones JE, Nelson EA,. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev 2010; (2): CD001737.
20. Falanga V, Sabolinski M,. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999; 7: 201-207.
21. Zaulyanov L, Kirsner RS,. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin Interv Aging 2007; 2: 93-98.
22. Veves A, Falanga V, Armstrong DG, Sabolinski ML,. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24: 290-295.
23. Gibbs S, van den Hoogenband HM, Kirtschig G, Richters CD, Spiekstra SW, Breetveld M, et al. Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol 2006; 155: 267-274.
24. Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S,. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 2007; 15: 708-717.
25. Caravaggi C, De GR, Pritelli C, Sommaria M, Dalla NS, Faglia E, et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 2003; 26: 2853-2859.
26. Edmonds M,. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8: 11-18.
27. Hanft JR, Surprenant MS,. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 2002; 41: 291-299.
28. Marston WA, Hanft J, Norwood P, Pollak R,. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003; 26: 1701-1705.
29. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998; 134: 293-300.
30. Auger FA, Lacroix D, Germain L,. Skin substitutes and wound healing. Skin Pharmacol Physiol 2009; 22: 94-102.
31. Mansbridge J,. Skin tissue engineering. J Biomater Sci Polym Ed 2008; 19: 955-968.
32. Omar AA, Mavor AI, Jones AM, Homer-Vanniasinkam S,. Treatment of venous leg ulcers with Dermagraft. Eur J Vasc Endovasc Surg 2004; 27: 666-672.
33. Phillips TJ, Manzoor J, Rojas A, Isaacs C, Carson P, Sabolinski M, et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol 2002; 138: 1079-1081.
34. Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H,. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 2008; (3): CD001898.